These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ganciclovir treatment of cytomegalovirus infection in heart-lung and double-lung transplant recipients. Cerrina J; Bavoux E; Le Roy Ladurie F; Herve P; Lafont D; Simonneau G; Dartevelle P Transplant Proc; 1991 Feb; 23(1 Pt 2):1174-5. PubMed ID: 1846457 [No Abstract] [Full Text] [Related]
3. Combination therapy with ganciclovir and intravenous IgG for cytomegalovirus infections in pediatric liver transplant recipients. Megison SM; Andrews WS Transplantation; 1991 Jul; 52(1):151-4. PubMed ID: 1650042 [No Abstract] [Full Text] [Related]
4. Therapy of cytomegalovirus infections with ganciclovir: a critical appraisal. Collier AC; Corey L Curr Clin Top Infect Dis; 1992; 12():309-28. PubMed ID: 1322676 [No Abstract] [Full Text] [Related]
5. Quantitative CMV-antigenemia test in the diagnosis of CMV infection and in the monitoring of response to antiviral treatment in liver transplant recipients. Lautenschlager I; Höckerstedt K; Salmela K Transplant Proc; 1994 Jun; 26(3):1719-20. PubMed ID: 8030100 [No Abstract] [Full Text] [Related]
7. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome. Reddy AJ; Zaas AK; Hanson KE; Palmer SM J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480 [TBL] [Abstract][Full Text] [Related]
8. Ganciclovir in the treatment of severe cytomegalovirus disease in liver transplant patients. Salmela K; Höckerstedt K; Lautenschlager I; Eklund B; Isoniemi H; Holmberg C; Ahonen J Transplant Proc; 1990 Feb; 22(1):238-40. PubMed ID: 2155492 [No Abstract] [Full Text] [Related]
9. Ganciclovir therapy for opportunistic cytomegalovirus disease in AIDS. Jacobson MA AIDS Clin Rev; 1990; ():149-63. PubMed ID: 1964576 [No Abstract] [Full Text] [Related]
10. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients. Mattes FM; Hainsworth EG; Geretti AM; Nebbia G; Prentice G; Potter M; Burroughs AK; Sweny P; Hassan-Walker AF; Okwuadi S; Sabin C; Amooty G; Brown VS; Grace SC; Emery VC; Griffiths PD J Infect Dis; 2004 Apr; 189(8):1355-61. PubMed ID: 15073671 [TBL] [Abstract][Full Text] [Related]
11. [Cytomegalovirus in liver transplantation: incidence and groups at risk]. Schiffer V; Mentha G; Giostra E; Belli D; Le Coultre C; Rohner A Schweiz Med Wochenschr; 1994 Apr; 124(15):631-6. PubMed ID: 8191266 [TBL] [Abstract][Full Text] [Related]
12. Detection of CMV-DNA in peripheral blood leukocytes of liver transplant patients after ganciclovir treatment. Loginov R; Höckerstedt K; Lautenschlager I Arch Virol; 2003 Jul; 148(7):1269-74. PubMed ID: 12827460 [TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus disease after liver transplantation: diagnostics and therapy. Wiens M; Schmidt CA; Lohmann R; Oettle H; Blumhardt G; Neuhaus P Transplant Proc; 1993 Aug; 25(4):2673-4. PubMed ID: 8395108 [No Abstract] [Full Text] [Related]
14. Efficacy of early treatment of cytomegalovirus infection by ganciclovir in renal transplant recipients. Rondeau E; Farquet C; Ruedin P; Fries D; Sraer JD Transplant Proc; 1990 Aug; 22(4):1813-4. PubMed ID: 2167536 [No Abstract] [Full Text] [Related]
15. Advances in the diagnosis, treatment, and prevention of cytomegalovirus infections after liver transplantation. Wiesner RH; Marin E; Porayko MK; Steers JL; Krom RA; Paya CV Gastroenterol Clin North Am; 1993 Jun; 22(2):351-66. PubMed ID: 8389735 [TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of sequential intravenous and oral ganciclovir versus prolonged intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in high-risk cytomegalovirus-seronegative liver transplant recipients with cytomegalovirus-seropositive donors. Winston DJ; Busuttil RW Transplantation; 2004 Jan; 77(2):305-8. PubMed ID: 14742998 [TBL] [Abstract][Full Text] [Related]
17. Deferred versus prophylactic therapy with gancyclovir for cytomegalovirus in allograft liver transplantation. Lianghui G; Shusen Z; Tingbo L; Yan S; Weilling W; Anwei L Transplant Proc; 2004 Jun; 36(5):1502-5. PubMed ID: 15251371 [TBL] [Abstract][Full Text] [Related]
18. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients. Winston DJ; Busuttil RW Transplantation; 2003 Jan; 75(2):229-33. PubMed ID: 12548129 [TBL] [Abstract][Full Text] [Related]
19. Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors. Shah T; Lai WK; Mutimer D Transpl Infect Dis; 2005 Jun; 7(2):57-62. PubMed ID: 16150091 [TBL] [Abstract][Full Text] [Related]